PAVM — PAVmed Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1624326 ·
Last close
$5.60
Market Cap
$40.09M
52W High
$9.67
52W Low
$3.85
ADV30
22,243
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | -60,000 | — | — | — |
| Dec 2025 | 52,000 | -33,000 | -6,648,000 | -1,263,000 | 38,812,000 | 1,538,000 | 16,512,000 |
| Sep 2025 | 5,000 | -50,000 | -4,681,000 | -5,383,000 | 38,069,000 | 3,103,000 | 12,282,000 |
| Jun 2025 | 6,000 | -35,000 | -4,635,000 | -11,921,000 | 43,893,000 | 4,004,000 | 12,474,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,245,000
Investing CF
$-47,000
Financing CF
$10,052,000
CapEx
$-47,000
Dividends Paid
—
Buybacks
$-26,197,000
EPS Diluted TTM
$-96.82
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-259,028,000
Inventory
$236,000
Receivables
$21,000
ST Investments
—
EBIT TTM
$-22,136,000
Pretax Income TTM
$-22,156,000
Interest Exp TTM
$20,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$85,000
EBITDA
$-24,313,000
Free Cash Flow
$-11,418,375
Enterprise Value
$39,125,640
Total Cash
$6,839,000
Total Debt
$17,010,000
Shares Out
7,159,034
Trailing EPS
$-48.31
Book Value
$5.71
ROE
-67.2%
ROA
-31.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 71,000 | -21,390,000 | 401,000 | 38,812,000 | 16,512,000 | — | -5,206,000 |
| Dec 2024 | 2,995,000 | -44,378,000 | 39,791,000 | 30,660,000 | 37,693,000 | — | -33,554,000 |
| Dec 2023 | 2,452,000 | -68,795,000 | -64,175,000 | 33,119,000 | 57,137,000 | — | -52,036,000 |
| Dec 2022 | 377,000 | -91,087,000 | -88,983,000 | 53,980,000 | 43,046,000 | — | -70,985,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.45
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RDGL | VIVOS INC | $40.45M | $0.08 | — |
| NEPH | NEPHROS INC | $39.41M | $3.63 | — |
| MCAG | Mountain Crest Acquisition Corp. V | $38.13M | $13.27 | — |
| TELA | TELA Bio, Inc. | $37.92M | $0.85 | — |
| MYO | MYOMO, INC. | $42.50M | $1.10 | — |
News headlines (Yahoo Finance, 1h cache)
How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target
2026-06-01 08:12 · Yahoo
PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ...
2026-05-15 23:01 · Yahoo
PAVmed (PAVM) Q4 2025 Earnings Transcript
2026-05-15 15:36 · Yahoo
PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates
2026-05-15 13:15 · Yahoo
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results
2026-05-15 12:00 · Yahoo
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates
2026-05-14 13:20 · Yahoo
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
2026-05-14 12:00 · Yahoo
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates
2026-05-13 22:40 · Yahoo
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
2026-05-12 21:40 · Yahoo
Will PAVmed Inc. (PAVM) Report Negative Earnings Next Week? What You Should Know
2026-05-08 14:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.